Autoimmune hepatitis surgery: Difference between revisions
Jump to navigation
Jump to search
| Line 15: | Line 15: | ||
Five-year survival rates, following transplantation for AIH, is about 75% | Five-year survival rates, following transplantation for AIH, is about 75% | ||
=='De novo’ AIH following liver transplantation== | =='De novo’ AIH following liver transplantation== | ||
AIH can recur in the transplanted liver despite aggressive immunosuppression | AIH can recur in the transplanted liver despite aggressive immunosuppression. | ||
Two patterns of disease are described: | Two patterns of disease are described: | ||
*First, one who has detectable anti-LKM1 antibodies at high titer in combination with a serum AST level >500 IU/l | *First, one who has detectable anti-LKM1 antibodies at high titer in combination with a serum AST level >500 IU/l | ||
*Second associated with the presence of ANA or ASMA at lower titers (>1:80) and lower AST levels | *Second associated with the presence of ANA or ASMA at lower titers (>1:80) and lower AST levels | ||
Treatment: | |||
*Reintroduction of corticosteroids and azathioprine | |||
==References== | ==References== | ||
Revision as of 15:46, 20 December 2017
|
Autoimmune hepatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Autoimmune hepatitis surgery On the Web |
|
American Roentgen Ray Society Images of Autoimmune hepatitis surgery |
|
Risk calculators and risk factors for Autoimmune hepatitis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Manpreet Kaur, MD [2]
Overview
Surgery
Liver Transplantation
Liver transplantation is indicated in the following condition:[1][2][3]
- Medical therapy fails
- Decompensated chronic liver disease
- Fulminant hepatic failure
- Hepatocellular carcinoma
- MELD score of >15 or a Child-Pugh score of >10277
Five-year survival rates, following transplantation for AIH, is about 75%
'De novo’ AIH following liver transplantation
AIH can recur in the transplanted liver despite aggressive immunosuppression. Two patterns of disease are described:
- First, one who has detectable anti-LKM1 antibodies at high titer in combination with a serum AST level >500 IU/l
- Second associated with the presence of ANA or ASMA at lower titers (>1:80) and lower AST levels
Treatment:
- Reintroduction of corticosteroids and azathioprine
References
- ↑ Reich DJ, Fiel I, Guarrera JV, Emre S, Guy SR, Schwartz ME, Miller CM, Sheiner PA (2000). "Liver transplantation for autoimmune hepatitis". Hepatology. 32 (4 Pt 1): 693–700. doi:10.1053/jhep.2000.16666. PMID 11003612.
- ↑ Ahmed M, Mutimer D, Hathaway M, Hubscher S, McMaster P, Elias E (1997). "Liver transplantation for autoimmune hepatitis: a 12-year experience". Transplant. Proc. 29 (1–2): 496. PMID 9123100.
- ↑ Khalaf H, Mourad W, El-Sheikh Y, Abdo A, Helmy A, Medhat Y, Al-Sofayan M, Al-Sagheir M, Al-Sebayel M (2007). "Liver transplantation for autoimmune hepatitis: a single-center experience". Transplant. Proc. 39 (4): 1166–70. doi:10.1016/j.transproceed.2007.02.030. PMID 17524922.